Cheryl Cheng
General Partner @ BlueRun Ventures
Menlo Park, United States
Cheryl Cheng is a Series A investor at BlueRun Ventures in Menlo Park focused on SaaS and Software. Cheryl Cheng joined BRV in 2008. She focuses on early stage consumer and mobile big data opportunities. Cheryl also runs BRV’s alumni entrepreneur and Fortune 500 programs to bring experience and resources to the current portfolio. Prior to BlueRun, Cheryl worked at Clorox and The Sharper Image launching new products and driving retail marketing with partners across Target, Walmart and grocery. Cheryl has a B.A. from Stanford University and an MBA from Kellogg School of Management where she was a Forte Scholar. She is a mentor at Stanford’s Bio-Design for Mobile Health course, a collaboration between Stanford’s School of Medicine and School of Engineering.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 47%
Last updated:
For AI agents: llms.txt
Industries Cheryl Cheng invests in
Stages Cheryl Cheng invests in
Countries Cheryl Cheng invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $2M–$5M
- Series A
- $4.7M–$30M
- Series B
- $17M–$53M
Investment Focus
Industry
- SaaS 3 (20%)
- Software 3 (20%)
- Health Care 3 (20%)
- Email 2 (13%)
- Content 2 (13%)
Stage
- Series A 8 (53%)
- Seed 3 (20%)
- Series B 2 (13%)
- Venture - Series Unknown 1 (7%)
Country
- United States 9 (60%)
- Canada 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Stuut provides an AI platform that automates accounts receivable work for companies. | $52.5M / Series B / Oct 07, 2026 | ||
| Stuut provides an AI platform that automates accounts receivable work for companies. | $67.6M / Venture - Series Unknown / Sep 02, 2026 | ||
| The AI agent for procurement | $30M / Series A / Feb 12, 2026 | ||
| SamaCare works with manufacturers' medically administered products to optimize the prior authorization process while remaining in compliance. The company offers a cloud-based workflow automation platform designed to streamline specialty drug prior authorization, enrollment, and benefit verification for medical practices. Additionally, SamaCareprovides premium services and data analytics to pharmaceutical brands, enhancing access to therapies. | $17M / Series B / May 21, 2024 | ||
| SamaCare works with manufacturers' medically administered products to optimize the prior authorization process while remaining in compliance. The company offers a cloud-based workflow automation platform designed to streamline specialty drug prior authorization, enrollment, and benefit verification for medical practices. Additionally, SamaCareprovides premium services and data analytics to pharmaceutical brands, enhancing access to therapies. | $12M / Series A / Feb 01, 2022 | ||
| Kiddo is a personalized smart at-home health monitoring platform for children. The Kiddo band is a smart pediatric band for children ages 3+ designed to track key vital signs – perspiration, activity, heart rate, and skin temperature. Along with the Kiddo companion app, Kiddo provides actionable health insights to parents combined with alerts andrecommendations. Kiddo also enables care integrations such as Telehealth and Doctor Appointments (in select markets only) thus enabling providers to manage admission rates and deliver cost-optimal proactive care. | $16M / Series A / Jan 04, 2022 | ||
| Gennev is a digital health company for women such as midlife and menopause. Gennev increases accessibility to information, health providers, and the community for women seeking relief for hormone-driven symptoms like hot flashes, insomnia, anxiety, and loss of libido. The company was founded in 2015 and headquartered in Seattle, Washington. | $4M / Seed / Aug 06, 2019 | ||
| Dyspatch, the product by Sendwithus, is a cloud-based, communications management platform that allows Enterprise organizations to centralize email security, compliance, and reputation management while streamlining collaborative creation, revision, and approval workflows. The GDPR-compliant solution empowers teams to deliver powerful, globalcommunications that engage customers, drive growth, and increase revenue. Sendwithus has been helping leading brands craft exceptional communications experiences since 2013. | $5M / Series A / Nov 21, 2017 | ||
| Dyspatch is an email production platform that helps Enterprise organizations create and change transactional and triggered emails faster, by centralizing template creation, approval, and publishing processes. The powerful API, visual editor, and built-in device testing allow for cutting-edge email strategy and execution, while helping establishconsistency in both branding and legal compliance across multiple teams, departments, and business units. | $5M / Series A / Nov 21, 2017 | ||
| Nom lets anyone host professional cooking, creative and DIY shows, and tap into its network of makers, creators, and chefs. | $4.7M / Series A / Mar 09, 2016 | ||
| See all 15 investments → | |||
Co-Investors
About BlueRun Ventures
BlueRun Ventures is a venture capital firm with offices in the United States, Shanghai, Beijing, and Korea. BlueRun invests in information technology, mobile, and consumer technologies, with an emphasis on mobile opportunities. BRV has invested in over 160 companies, with select exits from PayPal (acquired by eBay), Waze (acquired by Google), Topsy (acquired by Apple), Coupa (NASDAQ: COUP), and more. In 2005, BlueRun changed its name from Nokia Venture Partners. While branded as Nokia Venture Partners, the firm helped to build emerging market leaders such as Airgo, Bitfone, Cornice, PayPal, Wavemarket, and WiderThan.
BlueRun Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
John Malloy
General Partner & Founder
|
|||
Jonathan Ebinger
General Partner
|
|||
Jui Tan
Partner
|
|||
Kwan Yoon
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Cheryl Cheng invest in?
Cheryl Cheng invests primarily in SaaS, Software and Health Care startups, most often at Series A and Seed stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Cheryl Cheng invest in?
Cheryl Cheng typically joins rounds of $2M–$5M at Seed, $4.7M–$30M at Series A and $17M–$53M at Series B. These are whole funding-round sizes, not Cheryl Cheng's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Cheryl Cheng took part in.
How do I contact Cheryl Cheng?
Public channels for Cheryl Cheng include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Cheryl Cheng last invest?
The most recent investment recorded for Cheryl Cheng closed in Oct 2026. Shizune tracks 15 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
